News and Inspirational Stories

Lustgarten and Salk Institute announce strategic pancreatic cancer research partnership

Lustgarten and Salk Institute announce strategic pancreatic cancer research partnership

Posted On Feb 22,2022
Lustgarten and the Salk Institute announced a new strategic partnership supported by a $5 million grant and focused on identifying and validating potential targets for new pancreatic cancer drugs.

Discoveries

Real Talk: Survivor, Patient & Family Stories

Early Detection

Therapeutics

Precision Medicine

The Researchers

Thanks for signing up!
Tell us a little more about yourself: